Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HPV-16/18 E6/E7-Specific T Lymphocytes in Patients With Relapsed HPV-Associated Cancers

NCT02379520 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT02379520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02379520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HPV-16/18 E6/E7-Specific T Lymphocytes in Patients With Relapsed HPV-Associated Cancers
Lead sponsor
Baylor College of Medicine
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2015
Completion date
January 31, 2026
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human papillomavirus positive anal carcinoma, human papillomavirus positive cervical carcinoma, human papillomavirus positive oropharyngeal carcinoma, human papillomavirus positive penile carcinoma, human papillomavirus positive vulvar carcinoma, human papillomavirus-related carcinoma